Clinical Characteristics and Medical Management of Idiopathic Granulomatous Mastitis | Dermatology | JAMA Dermatology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Pereira  FA, Mudgil  AV, Macias  ES, Karsif  K.  Idiopathic granulomatous lobular mastitis.   Int J Dermatol. 2012;51(2):142-151. doi:10.1111/j.1365-4632.2011.05168.x PubMedGoogle ScholarCrossref
Pandey  TS, Mackinnon  JC, Bressler  L, Millar  A, Marcus  EE, Ganschow  PS.  Idiopathic granulomatous mastitis—a prospective study of 49 women and treatment outcomes with steroid therapy.   Breast J. 2014;20(3):258-266. doi:10.1111/tbj.12263 PubMedGoogle ScholarCrossref
Gautham  I, Radford  DM, Kovacs  CS,  et al.  Cystic neutrophilic granulomatous mastitis: the Cleveland Clinic experience with diagnosis and management.   Breast J. 2019;25(1):80-85. doi:10.1111/tbj.13160 PubMedGoogle ScholarCrossref
Joseph  KA, Luu  X, Mor  A.  Granulomatous mastitis: a New York public hospital experience.   Ann Surg Oncol. 2014;21(13):4159-4163. doi:10.1245/s10434-014-3895-z PubMedGoogle ScholarCrossref
Mohammed  S, Statz  A, Lacross  JS,  et al.  Granulomatous mastitis: a 10 year experience from a large inner city county hospital.   J Surg Res. 2013;184(1):299-303. doi:10.1016/j.jss.2013.06.047 PubMedGoogle ScholarCrossref
Sheu  J, Saavedra  AP, Mostaghimi  A.  Rapid response of tattoo-associated cutaneous sarcoidosis to minocycline: case report and review of the literature.   Dermatol Online J. 2014;20(8):13030/qt6dd1m2j9.PubMedGoogle Scholar
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    Research Letter
    January 22, 2020

    Clinical Characteristics and Medical Management of Idiopathic Granulomatous Mastitis

    Author Affiliations
    • 1The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York
    • 2Tribeca Skin Center, New York, New York
    • 3Department of Surgery, Bellevue Hospital Center, New York, New York
    • 4Department of Dermatology, Bellevue Hospital Center, New York, New York
    JAMA Dermatol. 2020;156(4):460-464. doi:10.1001/jamadermatol.2019.4516